Keywords
Comorbidities
Outcome
Invasive ventilacion
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To trace an epidemiological profile and compare length of stay, outcome and need for invasive ventilation in patients with comorbidities and those without comorbidities in individuals hospitalized due to COVID-19 in a referral hospital in the state of Pará, Brazil. Methods: This is a descriptive cross-sectional study, conducted with the analysis of 67 medical records of individuals of both sexes. Data on sex, age group, comorbidities, length of hospital stay, outcome and use of invasive ventilation (IV) were collected, these data were stratified and correlated separately and with each other: presence or absence of comorbidity, outcome, length of stay x High blood pressure (HBP) x outcome, length of stay x Diabetes x outcome, VI x HBP and VI x Diabetes. The data obtained were analyzed using descriptive statistics using the Biostat 5.3 software. The study was approved by the Research Ethics Committee. Results: Sample revealed that half of the patients had comorbidities, and among all, 58% were discharged and 25% died. While those with comorbidities remained hospitalized longer and were the ones who died the most and required IV. Conclusion: It was possible to establish a correlation between chronically ill individuals and their outcomes. However, the correct filling of medical records is still precarious, with many unusable.
References
ALI DM, et al. Role of Chest Computed Tomography versus Real Time Reverse Transcription Polymerase Chain Reaction for Diagnosis of COVID-19: a systematic review and meta-analysis. Interdisciplinary Perspectives On Infectious Diseases, 2021; 1-12.
BRASIL. Ministério da Saúde. 2022. Coronavírus Brasil. In: PAINEL GERAL: Painel Coronavírus. Disponível em: https://covid.saude.gov.br/. Acessado em: 31 de julho de 2022.
CALFEE CS, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomized controlled trials. The Lancet Respiratory Medicine, 2014; 2(8): 611-620.
DENG Y, et al. Associação da Hipertensão com a Gravidade e a Mortalidade de Pacientes Hospitalizados com COVID-19 em Wuhan, China: estudo unicêntrico e retrospectivo. Arquivos Brasileiros de Cardiologia, 2021; 5(117): 911-921.
DU Z, et al. Detection of antibodies against SARS‐CoV‐2 in patients with COVID‐19. Journal Of Medical Virology, 2020; 92(10): 1735-1738.
FADINI GP, et al. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest., 2020; 43(6): 867-869.
FANG X, et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging, 2020; 12(13): 12493-12503.
FERNÁNDEZ-DE-LAS-PEÑAS C, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. European Journal Of Internal Medicine, 2021; 92: 55-70.
GERVASIO CF, et al. Estenose traqueal após traqueostomia para ventilação mecânica em pneumonia COVID-19 -relato de 2 casos do norte da Itália. O jornal americano de relatos de casos, 2020; 21.
GHOLAMI M, et al. COVID-19 and healthcare workers: a systematic review and meta-analysis. International Journal Of Infectious Diseases, 2021; 104: 335-346.
GOLD J, et al. Race, Ethnicity, and Age Trends in Persons Who Died from COVID-19 - United States, May-August 2020. MMWR Morb Mortal Wkly Rep., 2020; 69(42): 1517-1521.
GUO W, et al. Diabetes is a risk factor for the progression and prognosis of covid-19. Diabetes Metab Res Rev., 2020; 36(7): e3319.
HAN X, et al. Novel Coronavirus Pneumonia (COVID-19) Progression Course in 17 Discharged Patients: Comparison of Clinical and Thin-Section CT Features During Recovery, Clinical Infectious Diseases, 2020; 71(15): 723–731.
KUMAR A, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes & Metabolic Syndrome, 2020; 14(4): 535-545.
LI J, et al. Epidemiology of COVID‐19: a systematic review and metaanalysis of clinical characteristics, risk factors, and outcomes. Journal Of Medical Virology, Shandong, China, 2020; 93(3): 1449-1458.
LOHIA P, et al. Metabolic syndrome and clinical outcomes in patients infected with COVID ‐19: does age, sex, and race of the patient with metabolic syndrome matter? Journal Of Diabetes, 2021; 13(5): 420-429.
MAHAMAT-SALEH Y, et al. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open, 2021; 11(10): 1-15.
MANDAL S, et al. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for covid-19. Thorax, 2020; 76(4): 396-398.
NANDY K, et al. Coronavirus disease (COVID-19): a systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Wuhan, China, 2020; 14(5): 1017-1025.
RAHIMI NR, et al. Bidirectional association between COVID-19 and the environment: a systematic review. Environmental Research, 2021; 194: 1-19.
RITTER WRG, RODRIGUES WF. Efeitos da ventilação mecânica não-invasiva com duas pressões no tratamento de adultos com Covid-19 que evoluíram com enfisema subcutâneo: uma revisão narrativa. Revista Eletrônica Acervo Saúde, 2022; 15(5): e10177.
SANTURA I, et al. Chest computed tomography versus RT-PCR in early diagnostics of COVID-19 – a systematic review with meta-analysis. Polish Journal Of Radiology, Department Of Nutrition And Drug Research, Institute Of Public Health, Faculty Of Health Sciences, Jagiellonian University Medical College, 2021; 86(1): 518-531.
SATHISH T, et al. Proportion of newly diagnosed diabetes in COVID ‐19 patients: a systematic review and metaanalysis. Diabetes, Obesity And Metabolism, 2020; 23(3): 870-874.
SHI S, et al. Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19 in Wuhan, China. Jama Cardiology, 2020; 5(7): 802.
SINGH AK, et al. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14(4): 303-310.
USHER K, et al. Life in the pandemic: social isolation and mental health. Journal Of Clinical Nursing, 2020; 29(15-16): 2756-2757.
VAIRA LA, et al. Anosmia and Ageusia: common findings in covid ⠰19 patients. The Laryngoscope, 2020; 130(7): 1787-1787.
VAN DOREMALEN N, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. New England Journal Of Medicine, 2020; 382(16): 1564-1567.
WANG D, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA, 2020; 323(11): 1061–1069.
WEI Y, et al. Comprehensive estimation for the length and dispersion of COVID-19 incubation period: a systematic review and meta-analysis. Infection, 2021; 1-11.
YUAN J, et al. The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients. Inflammation Research, 2020; 69(6): 599-606.
ZHENG YY, et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol., 2020; 17: 259–260.
DANIELSEN AC, et al. Sex disparities in COVID-19 outcomes in the United States: quantifying and contextualizing variation. Social Science & Medicine, 2022; 294: 114716.
TAKANASHI T, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature, 2020; 588: 315–320.